Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes
Evaluating the Effectiveness of a Structured Educational Program on Glycemic Control in Adolescents With Type 1 Diabetes: A Randomized Controlled Trial
1 other identifier
interventional
128
1 country
1
Brief Summary
Type 1 diabetes is becoming more common in Kuwaiti and Arab adolescents. Many young people with this condition struggle to keep their blood glucose levels under control, which can lead to diabetes-related complications and affect their quality of life. The goal of this clinical trial is to evaluate the effectiveness of a structured educational program on glycemic control among Arab adolescents with type 1 diabetes aged 11 to 14 years. Participants will be randomly assigned to one of two groups. The intervention group will receive the structured education program, and the control group will continue with standard care. All participants will undergo assessments that include:
- collecting demographic and diabetes management data
- measuring weight and height
- measuring HbA1c levels and lipid profile
- filling out questionnaires on quality of life, carbohydrate and insulin dosing knowledge, physical activity
- collecting dietary intake
- providing AGP report Participants in the intervention group will additionally be required to:
- attend the program for 4 consecutive days, one day for parents and three days for children
- fill out 3-day food diary records during the program
- attend a refresher course after 6 months Participants in the control group will have the opportunity to participate in the program after approximately six months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2025
CompletedStudy Start
First participant enrolled
May 18, 2025
CompletedFirst Posted
Study publicly available on registry
May 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 18, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 18, 2028
May 22, 2025
May 1, 2025
3 years
May 14, 2025
May 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in HbA1c Levels
Change in HbA1c Levels from baseline to 6 months
Baseline and 6 months
Change in %Time In Range (%TIR)
Change in %TIR from baseline to 6 months
Baseline and 6 months
Secondary Outcomes (4)
Change in Carbohydrate Counting and Insulin Adjustment Knowledge Scores
Baseline and 6 months
Change in Diabetes-Specific Quality of Life Scores
Baseline and 6 months
Change in Hypoglycemia Frequency
Baseline and 6 months
Change in Diabetes-Related Hospitalizations
Baseline and 6 months
Study Arms (2)
Control arm
NO INTERVENTIONParticipants will receive usual care at their treating hospitals.
Intervention arm
EXPERIMENTALParticipants will attend a structured education program over 4 days and a refresher course after 6 months.
Interventions
A structured group educational program culturally adapted from a UK model for adolescents with type 1 diabetes. The program aims to empower adolescents by providing knowledge and tools needed for effective diabetes management. It is delivered by dietitians, diabetes educators, and a pediatric endocrinologist in small groups. The curriculum targets both caregivers and adolescents: the first day is for parents and covers diabetes basics, management of hypoglycemia and hyperglycemia, insulin dosing, sick day management, and exercise considerations. The following three days focus on adolescents and include interactive sessions on the role of food in diabetes management, the effect of different nutrients on blood glucose levels, carbohydrate sources, reading food labels, advanced carbohydrate counting, and insulin dose adjustment.
Eligibility Criteria
You may qualify if:
- Arab adolescents
- Males and females aged 11 to 14 years.
- Have been diagnosed with type 1 diabetes for at least 6 months.
- Wearing a continuous glucose monitor (CGM).
- Individuals and their parents must be able to join the entire duration of the study.
- Individuals and their parents must voluntarily provide consent and assent.
You may not qualify if:
- Presence of learning disabilities or any known psychological issues.
- Attendance at any diabetes education or carbohydrate counting programs within the six months preceding the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dasman Diabetes Institute
Kuwait City, Sharq, 15462, Kuwait
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ebaa Al Ozairi, MD
Dasman Diabetes Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The investigators and data analysts will be masked to group assignments.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2025
First Posted
May 22, 2025
Study Start
May 18, 2025
Primary Completion (Estimated)
May 18, 2028
Study Completion (Estimated)
May 18, 2028
Last Updated
May 22, 2025
Record last verified: 2025-05